AORTIC COMPLIANCE IN YOUNG-PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引:81
|
作者
LEHMANN, ED
WATTS, GF
FATEMILANGROUDI, B
GOSLING, RG
机构
[1] UNIV LONDON,GUYS & ST THOMAS HOSP,UNITED MED & DENT SCH,DIV RADIOL SCI,LONDON,ENGLAND
[2] UNIV LONDON,GUYS & ST THOMAS HOSP,UNITED MED & DENT SCH,LONDON,ENGLAND
关键词
AORTIC COMPLIANCE; AORTIC DISTENSIBILITY; FAMILIAL HYPERCHOLESTEROLEMIA;
D O I
10.1042/cs0830717
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Aortic compliance and plasma lipid and lipoprotein levels were measured in 20 young patients with heterozygous familial hypercholesterolaemia and in 20 age- and sex-matched control subjects. 2. Patients with familial hypercholesterolaemia had significantly higher plasma cholesterol, low-density lipoprotein-cholesterol and triacylglycerol levels than control subjects (P<0.001, P<0.001 and P<0.005, respectively). The patients with familial hypercholesterolaemia also had significantly more compliant (distensible) aortas than the control subjects (P<0.001), a significant inverse correlation being observed between compliance and age (r = -0.73, P<0.001) and between compliance and mean blood pressure (r = -0.60, P<0.005). 3. When the effects of age and sex on aortic compliance were corrected for, the blood pressure effect disappeared, significant correlations being observed between normalized compliance and cholesterol (r = 0.50, P<0.03), low-density lipoprotein-cholesterol (r = 0.54, P<0.01), high-density lipoprotein-cholesterol (r = -0.44, P<0.05), low-density lipoprotein-/high-density lipoprotein-cholesterol ratio (r = 0.60, P<0.006) and duration of disease (r = 0.67, P<0.002). Multivariate regression analysis showed that the low-density lipoprotein-/high-density lipoprotein-cholesterol ratio (P<0.03) and duration of disease (P<0.04) were the best predictors of normalized compliance. 4. We suggest that the measurement of aortic compliance in young patients with familial hypercholesterolaemia may potentially be a useful, non-invasive, research tool for assessing their susceptibility to atheroma.
引用
收藏
页码:717 / 721
页数:5
相关论文
共 50 条
  • [21] HYPOCHOLESTEROLEMIC EFFECTS OF MEVINOLIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ILLINGWORTH, DR
    SEXTON, GJ
    JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06): : 1972 - 1978
  • [22] POLYGENETIC ABNORMALITIES IN JAPANESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Sekiguchi, Haruki
    Koike, Toshiharu
    Abe, Takuro
    Sakai, Akiko
    Sato, Kayoko
    Hagiwara, Nobuhisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1756 - 1756
  • [23] CORONARY ANGIOGRAPHIC CHARACTERISTICS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    GENDA, A
    UMEDA, K
    NAKAYAMA, A
    SHIMIZU, M
    KONISHI, K
    SUGIHARA, N
    SUEMATZU, T
    KITA, Y
    YOSHIMURA, A
    MABUCHI, H
    TAKEDA, R
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (08): : 940 - 940
  • [24] Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia
    Elisaf, M
    Bairaktari, H
    Siamopoulos, KC
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 (03) : 314 - 316
  • [25] PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ACCORDING THE RUSSIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY
    Bliznyuk, S. A.
    Rozhkova, T. A.
    Ezhov, M. V.
    Tripoten, M. I.
    Pogorelova, O. A.
    Chubykina, U. V.
    Tmoyan, N. A.
    Balakhonova, T. V.
    Afanasieva, M. I.
    Afanasieva, O. I.
    Pokrovsky, S. N.
    ATHEROSCLEROSIS, 2020, 315 : E193 - E193
  • [26] ALPHALIPOPROTEINS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MOORJANI, S
    GAGNE, C
    BRUN, LD
    TOUSSAINT, M
    LUPIEN, PJ
    UNION MEDICALE DU CANADA, 1980, 109 (04): : 530 - &
  • [27] GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Chaudhry, Ahsen
    Vesely, Kristin
    Trinder, Mark
    Brunham, Liam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1473 - 1473
  • [28] Patients' attitudes toward detection of heterozygous familial hypercholesterolemia
    Andersen, LK
    Jensen, HK
    Juul, S
    Faergeman, O
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) : 553 - 560
  • [29] Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia
    Reeskamp, Laurens F.
    Kastelein, John J. P.
    Moriarty, Patrick M.
    Duell, P. Barton
    Catapano, Alberico L.
    Santos, Raul D.
    Ballantyne, Christie M.
    ATHEROSCLEROSIS, 2019, 280 : 109 - 117
  • [30] Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
    Peterson, Amy L.
    Bang, Matthew
    Block, Robert C.
    Wong, Nathan D.
    Karalis, Dean G.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)